Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-bromophenacyl bromide | enzymatic activity of bromophenacylated PLA2 is approximate 0.06% of that of PLA2 | Naja atra |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Naja atra | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
venom | - |
Naja atra | - |
Synonyms | Comment | Organism |
---|---|---|
phospholipase A2 | - |
Naja atra |
PLA2 | - |
Naja atra |
General Information | Comment | Organism |
---|---|---|
physiological function | PLA2 induces caspase-dependent death in human SK-N-SH cells. PLA2 treatment induces Fas and FasL protein expression, leads to activation of p38 MAPK, inactivation of ERK, reactive oxygen species generation and elevation in intracellular Ca2+ concentration. PLA2-induced cell death is, in part, elicited by upregulation of Fas and FasL, which is regulated by Ca2+- and reactive oxygen species-evoked p38 MAPK activation, and suggests that non-catalytic PLA2 plays a role for the signaling pathway | Naja atra |